Douglas K. Bratton, 10% Owner at Denali Therapeutics Inc. (DNLI), sold 447,561 shares at $26.19 ($11.0M) on 2020-06-23, disclosed to the SEC on 2020-06-23.
Open-market sale of $11.0M DNLI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.20 | 82,481 | $2.0M | 18.1% |
| 2 | $24.20 | 82,481 | $2.0M | 18.1% |
| 3 | $25.00 | 62,439 | $1.6M | 14.1% |
| 4 | $24.66 | 65,373 | $1.6M | 14.6% |
| 5 | $24.66 | 65,373 | $1.6M | 14.6% |
| 6 | $25.12 | 24,683 |
| $620K |
| 5.6% |
| 7 | $25.12 | 24,683 | $620K | 5.6% |
| 8 | $25.69 | 16,777 | $431K | 3.9% |
| 9 | $25.69 | 16,777 | $431K | 3.9% |
| 10 | $26.19 | 3,247 | $85K | 0.8% |
| 11 | $26.19 | 3,247 | $85K | 0.8% |
| Total | $24.69 avg | 447,561 | $11.0M | 100% |
| Filing → |
| JUNO | SELL | 2015-07-02 | $2.2M | — | Filing → |
| JUNO | SELL | 2015-06-25 | $13.8M | — | Filing → |
| JUNO | BUY | 2014-12-24 | $15.0M | — | Filing → |